Complement-mediated enhancement of SARS-CoV-2 antibody neutralisation potency in vaccinated individuals.
Mellors J. et al, (2025), Nat Commun, 16
Clinical data and reporting quality in NMDAR-antibody encephalitis and pregnancy: a systematic review
Harris SL. et al, (2025), BMJ Neurology Open, 7, e001005 - e001005
SARS-CoV-2-specific immune responses and clinical outcomes after COVID-19 vaccination in patients with immune-suppressive disease.
Barnes E. et al, (2023), Nat Med, 29, 1760 - 1774
Evaluation of QuantiFERON SARS-CoV-2 interferon-γ release assay following SARS-CoV-2 infection and vaccination
Johnson SA. et al, (2023), Clinical and Experimental Immunology, 212, 249 - 261
Rapid escape of new SARS-CoV-2 Omicron variants from BA.2-directed antibody responses
Dijokaite-Guraliuc A. et al, (2023), Cell Reports, 42, 112271 - 112271
A delicate balance between antibody evasion and ACE2 affinity for Omicron BA.2.75
Huo J. et al, (2023), Cell Reports, 42, 111903 - 111903
Cellular immunity to SARS-CoV-2 following intrafamilial exposure in seronegative family members.
Jay C. et al, (2023), Front Immunol, 14
Constructing custom-made radiotranscriptomic signatures of vascular inflammation from routine CT angiograms: a prospective outcomes validation study in COVID-19
Kotanidis CP. et al, (2022), The Lancet Digital Health, 4, e705 - e716
130 IgLON5-antibody disease: a case series
Yapp N. et al, (2022), Journal of Neurology, Neurosurgery & Psychiatry, 93, e2.84 - e2.84
Comparison of two T-cell assays to evaluate T-cell responses to SARS-CoV-2 following vaccination in naïve and convalescent healthcare workers
Phillips E. et al, (2022), Clinical and Experimental Immunology, 209, 90 - 98
Fatal COVID-19 outcomes are associated with an antibody response targeting epitopes shared with endemic coronaviruses
McNaughton AL. et al, (2022), JCI Insight, 7
Antibody escape of SARS-CoV-2 Omicron BA.4 and BA.5 from vaccine and BA.1 serum
Tuekprakhon A. et al, (2022), Cell, 185, 2422 - 2433.e13
Potent cross-reactive antibodies following Omicron breakthrough in vaccinees
Nutalai R. et al, (2022), Cell, 185, 2116 - 2131.e18
Further antibody escape by Omicron BA.4 and BA.5 from vaccine and BA.1 serum
Tuekprakhon A. et al, (2022)
A simple, robust flow cytometry-based whole blood assay for investigating sex differential interferon alpha production by plasmacytoid dendritic cells
Sampson O. et al, (2022), Journal of Immunological Methods, 504, 113263 - 113263
An Observational Cohort Study on the Incidence of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection and B.1.1.7 Variant Infection in Healthcare Workers by Antibody and Vaccination Status
Lumley SF. et al, (2022), Clinical Infectious Diseases, 74, 1208 - 1219